Xylo Technologies: ParaZero Received Order from a Leading Tier-One Defense Company for 50 Drone Safety Systems

Rhea-AI Summary

Xylo Technologies (Nasdaq: XYLO) announced that ParaZero Technologies (Nasdaq: PRZO), an aerospace company 18.68% owned by Xylo, has initiated a partnership with a leading Tier 1 defense OEM to adapt its drone safety systems for military and medical missions. ParaZero received an initial order for 50 systems for testing, with plans to develop adaptations for medical delivery systems. Upon successful testing, the customer intends to purchase hundreds more systems for a pilot program. The project aims to enhance medical field mission deliveries in critical and remote areas, with completion expected by the end of 2024. ParaZero's goal is to develop a scalable, cost-effective mass production system for wider deployment, potentially entering defense markets and improving healthcare logistics.

Positive

• Initial order received for 50 drone safety systems from a leading Tier 1 defense company
• Potential for hundreds of additional system orders upon successful testing
• Expansion into defense and medical mission markets
• Development of scalable, cost-effective mass production system
• Project completion expected by end of 2024, leading to commercial production

Negative

• None.

Aerospace Industry Analyst

This order marks a significant milestone for ParaZero, demonstrating the versatility and adaptability of their drone safety systems. The partnership with a Tier 1 defense OEM validates the technology's potential in high-stakes applications. The initial order of 50 systems, with the prospect of hundreds more, indicates a substantial market opportunity.

The focus on medical field missions highlights an emerging niche in drone applications, potentially opening up new revenue streams. If successful, this could position ParaZero as a key player in military medical logistics. The timeline for completion by end-2024 suggests a rapid development cycle, which could accelerate ParaZero's market penetration and revenue growth.

Investors should note the potential for scalable, recurring revenue if the pilot program succeeds and leads to wider adoption. However, the defense sector's stringent requirements and potential for project delays pose risks that warrant careful monitoring.

Medical Technology Expert

The integration of drone technology into medical field missions represents a significant advancement in healthcare logistics. ParaZero's safety systems could be game-changing for delivering critical medical supplies to remote or dangerous areas, potentially saving countless lives.

The adaptation of these systems for medical deliveries addresses a crucial need in emergency medicine and disaster response. If successful, this technology could revolutionize triage and first-response scenarios, allowing for rapid deployment of medical resources without risking additional human lives.

The focus on developing a scalable, cost-effective mass production system is particularly promising. It suggests that this technology could become widely accessible, not just for military applications but potentially for civilian emergency services and humanitarian aid organizations as well. This broader applicability could significantly expand the market potential for ParaZero's technology.

Defense Industry Analyst

This partnership signifies ParaZero's strategic entry into the defense sector, a move that could substantially boost its market presence and revenue. The involvement of a Tier 1 defense OEM lends significant credibility to ParaZero's technology and could pave the way for additional military contracts.

The focus on medical mission deliveries addresses a critical operational need in modern warfare and peacekeeping operations. Success in this niche could position ParaZero as a vital supplier in military logistics and support systems.

However, investors should be aware of the lengthy procurement cycles and stringent testing requirements typical in defense contracts. While the potential rewards are significant, the path to full-scale deployment may be protracted. The projected timeline for completion by end-2024 is ambitious and may be subject to extensions, which could impact short-term financial expectations.

Overall, this development represents a positive step for ParaZero, with the potential to significantly expand its market reach and long-term revenue prospects.

TEL AVIV, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” or the “Company”), a technology-based company engaged in advanced innovative technologies, announced today that ParaZero Technologies Ltd. (Nasdaq: PRZO) ( “ParaZero”), an aerospace company focused on drone safety systems for defense and commercial drones and urban air mobility aircraft (18.68% owned by Xylo), initiated a partnership with a leading Tier 1 defense OEM company to adapt and integrate its advanced drone safety system for operational military and medical mission use. ParaZero received an initial order as part of a wider collaboration that aims to enhance the efficiency and safety of medical field mission’s deliveries, particularly in critical and remote areas.

In the initial phase, ParaZero will provide 50 systems to the customer for testing, during which time ParaZero will develop and validate the necessary adaptations for the medical delivery system. Upon successful completion of the testing phase, the customer plans to purchase additional hundreds of systems for a pilot program. These stages are expected to be completed by the end of 2024, after which the adapted systems will enter commercial production for operational use by this customer and other customers. ParaZero’s target is to develop a scalable, cost-effective mass production system that can be deployed widely, ensuring that medical deliveries are safer, faster, and more reliable.

ParaZero's drone safety systems, initially developed for defense and commercial applications, will be adapted and integrated to meet the unique mission and operational field requirements for medical operations. This initiative underscores the ParaZero's commitment to enter defense markets, as well as leveraging its technology to save lives and improve healthcare logistics.

About ParaZero Technologies

ParaZero (Nasdaq: PRZO) is a -leading developer of autonomous parachute safety systems technologies for commercial and military platforms as well as for urban air mobility (UAM) aircraft. Started in 2014 by a passionate group of aviation professionals and drone industry veterans, ParaZero designs smart, autonomous parachute safety systems designed to enable safe flight operations over populated areas and beyond-visual-line-of-sight (BVLOS) as well as for various military applications including Counter UAS. For more information about ParaZero, please visit https://parazero.com.

About Xylo
Based in Israel, Xylo Technologies Ltd. (Nasdaq: XYLO) is a technologies company that is focused on innovative growth partnerships, mainly in advanced medical solutions, digital commerce, and electric vehicle markets. Xylo’ affiliations in the medical solutions arena include the ownership in Polyrizon Ltd. The Company’s affiliates in digital commerce include Gix Internet Ltd., and Eventer Technologies Ltd. In the electric vehicle market, Charging Robotics, Inc. and Revoltz Ltd. are also part of the Company’s portfolio of technology solution providers. Other affiliations of the Company include Parazero Technologies Ltd. and Zig Miami 54 LLC.

Xylo is traded on The Nasdaq Capital Market. To learn more about Xylo’s advanced technologies, please visit  https://ir.xylotech.ai/.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements such as the expected success of the ParaZero collaboration and integration of its systems in the market. Because such statements deal with future events and are based on Xylo’ current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Xylo could differ materially from those described in or implied by the statements in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Xylo undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Xylo is not responsible for the contents on third-party websites.

Company Contact:
Tali Dinar
Chief Financial Officer
ir@xylotech.ai

Investor Relations Contact:
Michal Efraty
Investor Relations,
michal@efraty.com

FAQ

What is the initial order size for ParaZero's drone safety systems from the Tier 1 defense company?

ParaZero received an initial order for 50 drone safety systems from the Tier 1 defense company for testing purposes.

What is the potential future order size for ParaZero (PRZO) from the defense company?

Upon successful testing, the defense company plans to purchase additional hundreds of systems for a pilot program.

When is the project with the Tier 1 defense company expected to be completed for ParaZero (PRZO)?

The project stages, including testing and adaptation, are expected to be completed by the end of 2024.

What is the main application for ParaZero's (PRZO) adapted drone safety systems in this partnership?

The adapted drone safety systems will be used to enhance the efficiency and safety of medical field mission deliveries, particularly in critical and remote areas.

How does this partnership align with ParaZero's (PRZO) business strategy?

This partnership underscores ParaZero's commitment to enter defense markets and leverage its technology to save lives and improve healthcare logistics.